| VITROLIFE AB SK 0,2 |
| Schweden |
| Gesundheit |
| SE0011205202 / A2JLT3 |
| VTFN (Frankfurt) |
| FRA:VTFN, ETR:VTFN, VTFN:GR |
| - |
| https://www.vitrolife.com.. |
|
Vitrolife AB is a leading global provider of medical devices and genetic testing services dedicated to the reproductive-health market, specializing in assisted reproduction technologies. The company develops, manufactures, and distributes specialized..
>Volltext.. |
| 1194.28 Mio. EUR |
| 1267.67 Mio. EUR |
| 322.36 Mio. EUR |
| 97.86 Mio. EUR |
| -469.71 Mio. EUR |
| -3.47 EUR |
| 150.45 Mio. EUR |
| 75.83 Mio. EUR |
| 59.52 Mio. EUR |
| 1.32 |
| 1% |
| -1135.07% |
| 0.1 EUR |
| 1.2% |
| 1.21% |
| 30.04.25 - 0.099451005€ 26.04.24 - 0.09041€ >weitere anzeigen... |
| - |
| VITROLIFE |
| 06.04.26 |
|
||||
|